CEO: Ludwig N. Hantson

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Alexion Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.


Key numbers

Market Capitalization:23981305670
Shares Outstanding: 221291000
Float: 220561403.573
Next Earning Date:2020-02-03
TTm EPS: 6.5702
TTm Dividend Rate:
200 days moving average:119.7
50 days moving average: 103.76
One day percent Change: 0.92



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,